Regional Disparities in Qualified Health Plans’ Prior Authorization Requirements for HIV Pre-exposure Prophylaxis in the United States
Open Access
- 1 June 2020
- journal article
- research article
- Published by American Medical Association (AMA) in JAMA Network Open
- Vol. 3 (6) , e207445
Abstract
Biomedical HIV prevention with HIV pre-exposure prophylaxis (PrEP) has been available since 2012 and, if widely used, may help end the HIV epidemic in the United States.1-3 The efficacy of PrEP in reducing HIV acquisition exceeds 90% for sexual encounters and exceeds 70% for injection drug use.4 Averting 1 new HIV transmission saves the health care system more than $400 000 in lifetime costs.5 However, PrEP use lags behind the HIV epidemic, particularly in the South.6-8 The most frequently cited barriers in the South for low PrEP use include lack of clinicians with PrEP knowledge, absence of health insurance, stigma, and underestimation of personal HIV risk.9-13 Improved HIV biomedical prevention through access to PrEP is 1 of the essential components of the federal government’s Ending the HIV Epidemic initiative.3Keywords
This publication has 38 references indexed in Scilit:
- Insurer Competition In Federally Run Marketplaces Is Associated With Lower PremiumsHealth Affairs, 2015
- State-level structural sexual stigma and HIV prevention in a national online sample of HIV-uninfected MSM in the United StatesAIDS, 2015
- Knowledge, Attitudes, and Likelihood of Pre-Exposure Prophylaxis (PrEP) Use Among US Women at Risk of Acquiring HIVAIDS Patient Care and STDs, 2015
- Using Drugs to Discriminate — Adverse Selection in the Insurance MarketplaceNew England Journal of Medicine, 2015
- HIV-Related Stigma Among African-American Youth in the Northeast and Southeast USAIDS and Behavior, 2014
- Updates of Lifetime Costs of Care and Quality-of-Life Estimates for HIV-Infected Persons in the United StatesJAIDS Journal of Acquired Immune Deficiency Syndromes, 2013
- Emtricitabine-Tenofovir Concentrations and Pre-Exposure Prophylaxis Efficacy in Men Who Have Sex with MenScience Translational Medicine, 2012
- Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with MenNew England Journal of Medicine, 2010
- Prescription Drug Cost SharingJAMA, 2007
- Effect of a Prior-Authorization Requirement on the Use of Nonsteroidal Antiinflammatory Drugs by Medicaid PatientsNew England Journal of Medicine, 1995